Document is current

Any future updates will be listed below

Baseline circulating IL-17 predicts toxicity while TGF-β1 and IL-10 are prognostic of relapse in ipilimumab neoadjuvant therapy of melanoma

Crossref DOI link: https://doi.org/10.1186/s40425-015-0081-1

Published Online: 2015-09-15

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark